Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Eur J Case Rep Intern Med ; 7(12): 002088, 2020.
Article in English | MEDLINE | ID: mdl-33313019

ABSTRACT

We present a case of Takotsubo (stress-induced) cardiomyopathy (TCM) in a healthcare worker that occurred during the COVID-19 pandemic. TCM, or broken-heart syndrome, has various presentations. This case sheds light on how stress due to the COVID-19 pandemic may cause cardiac illness in healthcare workers. LEARNING POINTS: The various symptoms indicating Takotsubo cardiomyopathy are characterized and defined.Physicians should be aware that stress in healthcare workers may cause heart disease.

5.
Exp Physiol ; 93(8): 982-93, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18487314

ABSTRACT

Hormonal replacement therapy (HRT) has recently been shown to increase the risk of cardiovascular events in women. However, it is not clear whether the adverse effect of HRT is related to dosage and/or the presence of progestin. Using a mouse model of myocardial infarction (MI), we studied the dose-effect of oestrogen replacement on mortality and cardiac remodelling and dysfunction post-MI in the absence of progestin. Six-week-old females were subjected to ovariectomy (OVX). A pellet containing a low, moderate or high dose of 17beta-oestradiol (E(2); 0.42, 4.2 or 18.8 microg day(-1)) or placebo was implanted subcutaneously on the day of OVX. Myocardial infarction was induced 8 weeks later, and cardiac morphology and function were evaluated 8 weeks after MI. We found that E(2) at moderate and high doses adversely affected mortality. A low dose of E(2) that restored plasma oestrogen close to physiological levels had no significant effect on mortality but tended to improve cardiac function and remodelling, associated with reduced fibrosis and increased capillary density. At the moderate dose, E(2) exacerbated cardiac fibrosis, hypertrophy, dysfunction and dilatation, associated with liver and kidney enlargement and ascites. Protein kinase C and extracellular signal-regulated kinase were increased by MI but were not affected by E(2). In summary, E(2) at a low dose tended to be cardioprotective. At increased doses that raised plasma oestrogen far beyond the physiological level, E(2) was detrimental to the heart. Our data suggest that dosage should be an important consideration when studying the effect of oestrogen replacement on the heart.


Subject(s)
Estrogen Replacement Therapy , Estrogens/pharmacology , Heart/drug effects , Myocardial Infarction/metabolism , Myocardial Infarction/pathology , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Estrogens/blood , Female , Mice , Mice, Inbred C57BL , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Myocardial Infarction/mortality , Myocardium/metabolism , Myocardium/pathology , Ovariectomy , Protein Kinase C/metabolism , Testosterone/blood
6.
Gend Med ; 4(3): 230-47, 2007 Sep.
Article in English | MEDLINE | ID: mdl-18022590

ABSTRACT

BACKGROUND: It is well established that premenopausal women are protected from cardiovascular disease. This gender difference in favor of females is also demonstrated in animal studies. Our research group previously found that female mice had much lower incidence of cardiac rupture and mortality than did males during the acute phase of myocardial infarction (MI); however, the mechanisms responsible for such protection are not fully understood. OBJECTIVE: The aim of this study was to determine whether the favorable cardiac effect observed in female mice with MI is due to an augmented healing process that includes less inflammation, reduced matrix degradation, and enhanced neovascularization. METHODS: Twelve-week-old male and female C57BL/6J mice were subjected to MI by ligating the left anterior descending coronary artery and then euthanized at 1, 4, 7, or 14 days post-MI. Inflammatory cell infiltration and myofibroblast transformation, matrix metalloproteinase (MMP)-2 and MMP-9 activity, tissue inhibitor of metalloproteinase (TIMP)-I expression, and neovascularization were examined by immunohistochemistry, zymography, Western blot, and laser scanning confocal microscopy, respectively. Cardiac function was evaluated by echocardiography on day 14. RESULTS: We found that: (1) neutrophil infiltration during the early phase of MI (1-4 days) was much lower in females than in males and was associated with lower MMP-9 activity and higher TIMP-1 protein expression, indicating less-exaggerated inflammation and extracellular matrix degradation in females; (2) myofibroblast transformation, as indicated by expression of alpha-smooth muscle actin, was significantly greater in females than in males at day 7 of MI (P<0.05), indicating facilitated collagen deposition and scar formation; and (3) neovascularization (vascular area in the infarct border) was markedly increased in females, and was associated with better preserved cardiac function and less left ventricular dilatation. CONCLUSION: Our data suggest that less-exaggerated early inflammation and augmented reparative fibrotic response, indicated by enhanced myofibroblast transformation, may contribute greatly to low rupture rates in females during the acute and subacute phases of MI, whereas enhanced neovascularization may lead to better preserved cardiac function post-MI.


Subject(s)
Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Myocardial Infarction/physiopathology , Neutrophil Infiltration , Recovery of Function , Tissue Inhibitor of Metalloproteinase-1/metabolism , Animals , Blotting, Western/methods , Echocardiography , Female , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Neovascularization, Pathologic , Sex Factors , Ventricular Remodeling
SELECTION OF CITATIONS
SEARCH DETAIL